In a recent media event hosted by KFF, Lina Khan, chair of the Federal Trade Commission (FTC), issued a warning about the potential for price fixing in healthcare facilitated by technological advancements. Khan highlighted how algorithms enable companies to fix prices without explicit coordination, presenting a new challenge for regulators.
Khan emphasized the potential harm that technological advances can inflict on consumers. She pointed out that algorithms are increasingly utilized by companies to discriminate against individual consumers, ushering in what she termed “a somewhat novel era of pricing.”
The FTC, along with the Justice Department, has been particularly active in challenging mergers, setting a record for merger challenges in the previous fiscal year. Notably, the FTC successfully blocked Illumina’s $7 billion-plus acquisition of cancer-screening company Grail last year.
To empower consumers in reporting suspected anticompetitive behavior in the healthcare industry, the FTC, Justice Department and Health and Human Services Department launched healthycompetition.gov on April 18.
Read more: Federal Agencies Investigate Private-Equity Impact on Healthcare Costs
However, the American Hospital Association (AHA), a major industry trade group, has criticized the Biden administration’s approach to antitrust enforcement, expressing concerns about proposed guidelines that they argue reflect hostility towards mergers.
Price fixing, which eliminates market competition and drives up costs for consumers, remains illegal even when facilitated through algorithms, Khan stressed. She explained how companies can effectively set identical prices using algorithms without direct coordination, likening it to residential property managers using similar algorithms.
Furthermore, Khan highlighted the FTC’s scrutiny of artificial intelligence and algorithms used to set prices for individual consumers based on behavioral data. As healthcare companies evolve their business structures to maximize profits, the FTC is adapting its analytical approach to address potential consumer harm.
Khan emphasized the importance of hiring technologists to decipher complex algorithms, citing successful legal actions enabled by their expertise. She noted that while the FTC traditionally policed healthcare through challenging local or regional hospital mergers, the landscape of consolidation in healthcare has evolved, necessitating a nuanced regulatory approach.
Source: Washington Post
Featured News
Subscribers Defend $4.7 Billion Antitrust Verdict Against NFL in Court Filings
Jul 19, 2024 by
CPI
Von der Leyen Calls for Competition Policy to Boost EU Companies’ Growth
Jul 19, 2024 by
CPI
Vermont AG Sues Pharmacy Benefit Managers Over Drug Prices
Jul 18, 2024 by
CPI
Australians Face Increased Stamp Prices Following ACCC Approval
Jul 18, 2024 by
CPI
Live Nation Seeks Dismissal of DOJ Antitrust Allegations
Jul 18, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Private Equity Roll-Up Schemes
Jun 28, 2024 by
CPI
The FTC’s Focus on Private Equity is Warranted
Jun 28, 2024 by
CPI
Unraveling the Roll-Up: Private Equity’s Misunderstood Investment Strategy
Jun 28, 2024 by
CPI
Antitrust Focus on Private Equity Funds and Serial Acquisitions
Jun 28, 2024 by
CPI
Private Equity Roll-Ups Amidst Heightened Antitrust Enforcement
Jun 28, 2024 by
CPI